APPLICATION
ANDA202594
TYPE
ANDA
ORIGINAL APPROVAL
2015-10-22
LATEST ACTION
2023-10-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
DROSPIRENONE AND ETHINYL ESTRADIOLPrescription
DROSPIRENONE 3MG, ETHINYL ESTRADIOL 0.02MG · TABLET · ORAL
Approval history
2023-10-24Labeling · Supplement 9 · standardAP
2023-10-24Labeling · Supplement 6 · standardAP
2020-06-04Labeling · Supplement 2 · standardAP
2015-10-22UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.